Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis of the Precision Medicine in Mental Health Care (PRIME) study showed that ...

SALT LAKE CITY, Sept. 3, 2025 – Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six ...

The test is intended for patients with moderate to severe depression and differentiates between unipolar and bipolar depression.

Antidepressant choice or strategy may not alter overall cognition in older adults with treatment-resistant depression, but ...

Like many first-time mothers, Lisette Lopez-Rose thought childbirth would usher in a time of joy. Instead, she had panic attacks as she imagined that something bad was going to happen to her baby, and ...

Knowable Magazine reports on a new blood test, myLuma, predicting postpartum depression risk with over 80% accuracy, aiding ...

A commonly prescribed antidepressant may improve core emotional symptoms of depression much faster than previously thought. A new analysis reveals that while the drug sertraline offers relief from ...

Cholesterol medication bringing you down? Cholesterol-lowering statin medications are the number one money-making medication. These drugs generated 35.3 billion dollars in sales worldwide in 2009.

Postpartum depression affects some one in eight women in the United States. It typically occurs in the first weeks after childbirth, after a sudden drop in levels of estrogen and progesterone.